Ptc Therapeutics (PTCT) Research & Development (2016 - 2025)
Historic Research & Development for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $100.2 million.
- Ptc Therapeutics' Research & Development fell 3794.89% to $100.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $446.9 million, marking a year-over-year decrease of 1584.97%. This contributed to the annual value of $534.5 million for FY2024, which is 1981.55% down from last year.
- As of Q3 2025, Ptc Therapeutics' Research & Development stood at $100.2 million, which was down 3794.89% from $113.0 million recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Research & Development ranged from a high of $195.1 million in Q1 2023 and a low of $100.2 million during Q3 2025
- Moreover, its 5-year median value for Research & Development was $134.5 million (2021), whereas its average is $142.9 million.
- In the last 5 years, Ptc Therapeutics' Research & Development skyrocketed by 4928.14% in 2021 and then plummeted by 4048.45% in 2024.
- Over the past 5 years, Ptc Therapeutics' Research & Development (Quarter) stood at $149.8 million in 2021, then grew by 25.93% to $188.7 million in 2022, then crashed by 35.69% to $121.4 million in 2023, then grew by 2.82% to $124.8 million in 2024, then fell by 19.73% to $100.2 million in 2025.
- Its Research & Development was $100.2 million in Q3 2025, compared to $113.0 million in Q2 2025 and $109.0 million in Q1 2025.